These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35481416)

  • 61. Impact of embedded medication assistance program specialists on medication access in outpatient oncology clinics.
    Fudzie SS; Luong B; Jean SJ; Francart SJ
    J Oncol Pharm Pract; 2021 Dec; 27(8):1829-1834. PubMed ID: 33121352
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Economic value and characteristics of cloud pharmacy for children based on internet hospital in western China during the COVID-19 pandemic: Cross-sectional survey study.
    Yang B; Wen Q; Zhang Y; Wang X; Yin X; Li Q; Li Q; Song L
    Front Public Health; 2022; 10():1034450. PubMed ID: 36408041
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Difficulty and help with activities of daily living among older adults living alone during the COVID-19 pandemic: a multi-country population-based study.
    Chen S; Jones LA; Jiang S; Jin H; Dong D; Chen X; Wang D; Zhang Y; Xiang L; Zhu A; Cardinal RN
    BMC Geriatr; 2022 Mar; 22(1):181. PubMed ID: 35246064
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacy-based immunization in rural USA during the COVID-19 pandemic: A survey of community pharmacists from five southeastern states.
    AlMahasis SO; Fox B; Ha D; Qian J; Wang CH; Westrick SC
    Vaccine; 2023 Apr; 41(15):2503-2513. PubMed ID: 36898932
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Generic drug discount programs: are prescriptions being submitted for pharmacy benefit adjudication?
    Tungol A; Starner CI; Gunderson BW; Schafer JA; Qiu Y; Gleason PP
    J Manag Care Pharm; 2012; 18(9):690-700. PubMed ID: 23206212
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Schizophrenia population health management: perspectives of and lessons learned from population health decision makers.
    Roach M; Lin D; Graf M; Pednekar P; Chou JW; Benson C; Doshi JA
    J Manag Care Spec Pharm; 2021 Oct; 27(10-a Suppl):S2-S13. PubMed ID: 34652218
    [No Abstract]   [Full Text] [Related]  

  • 67. Pharmacy responses during the COVID-19 pandemic: a questionnaire survey.
    Watanabe S; Inami Y; Kimura H; Yano T; Ono M; Akizuki R; Nawata Y; Tanaka T; Furukawa K; Tanaka M
    BMC Public Health; 2022 Jan; 22(1):170. PubMed ID: 35078434
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Implementing medicare education for medication access: A review of the literature using the RE-AIM framework.
    Cooper JB; Scotti A; Carr ML
    Res Social Adm Pharm; 2023 Jan; 19(1):16-27. PubMed ID: 36085121
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Impact of Out-of-Pocket Pharmacy Costs on Branded Medication Adherence Among Patients with Type 2 Diabetes.
    Bibeau WS; Fu H; Taylor AD; Kwan AY
    J Manag Care Spec Pharm; 2016 Nov; 22(11):1338-1347. PubMed ID: 27783549
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Factors associated with choice of pharmacy setting among DoD health care beneficiaries aged 65 years or older.
    Linton A; Garber M; Fagan NK; Peterson M
    J Manag Care Pharm; 2007 Oct; 13(8):677-86. PubMed ID: 17970605
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Community pharmacy during the COVID-19 pandemic: a cross-sectional study.
    Merks P; Świeczkowski D; Bilmin K; Jakubowska M; Drelich E; Lewicki J; Gołębiewska W; Bogusz J; Jaguszewski M
    Przegl Epidemiol; 2020; 74(4):620-633. PubMed ID: 33861029
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Benefits, Problems, and Potential Improvements in a Nationwide Patient Portal: Cross-sectional Survey of Pharmacy Customers' Experiences.
    Sääskilahti M; Ojanen A; Ahonen R; Timonen J
    J Med Internet Res; 2021 Nov; 23(11):e31483. PubMed ID: 34730542
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Drug Recovery and Copay Assistance Program in a Community Cancer Center: Charity and Challenges.
    Siegel RD; Slough RG; Crosswell HE; Standifer TM; Borron ME; Pringle DL; Hancock KK; Widener LH; Hill EB; Spann TF; Stoeppler-Biege KM
    J Oncol Pract; 2019 Jul; 15(7):e628-e635. PubMed ID: 31162998
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacy Emergency Preparedness and Response (PEPR): a proposed framework for expanding pharmacy professionals' roles and contributions to emergency preparedness and response during the COVID-19 pandemic and beyond.
    Aruru M; Truong HA; Clark S
    Res Social Adm Pharm; 2021 Jan; 17(1):1967-1977. PubMed ID: 32389631
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Primary medication nonadherence rates to specialty disease-modifying antirheumatic drugs for rheumatoid arthritis within a health system specialty pharmacy.
    Petry L; Zuckerman AD; DeClercq J; Choi L; Lynch B; Saknini M
    J Manag Care Spec Pharm; 2023 Jul; 29(7):732-739. PubMed ID: 37404072
    [No Abstract]   [Full Text] [Related]  

  • 76. Community pharmacy cognitive services during the COVID-19 pandemic: A descriptive study of practices, precautions taken, perceived enablers and barriers and burnout.
    Okuyan B; Bektay MY; Kingir ZB; Save D; Sancar M
    Int J Clin Pract; 2021 Dec; 75(12):e14834. PubMed ID: 34510660
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of COVID-19 pandemic on training of pharmacy residents and fellows: Results from a national survey of postgraduate pharmacy trainees.
    Moore WJ; Webb A; Morrisette T; Sullivan LK; Alosaimy S; Hossain S; Howe Z; Vlashyn OO; Paloucek FP; Rybak MJ; Wang SK
    Am J Health Syst Pharm; 2021 Jun; 78(12):1104-1111. PubMed ID: 33740818
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Medication Therapy Management: 10 Years of Experience in a Large Integrated Health Care System.
    de Oliveira DR; Brummel AR; Miller DB
    J Manag Care Spec Pharm; 2020 Sep; 26(9):1057-1066. PubMed ID: 32857651
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A copay foundation assistance support program for patients receiving intravenous cancer therapy.
    Rajurkar SP; Presant CA; Bosserman LD; McNatt WJ
    J Oncol Pract; 2011 Mar; 7(2):100-2. PubMed ID: 21731517
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Specialty pharmacy turnaround time impediments, facilitators, and good practices.
    Gabriel MH; Kotschevar CM; Tarver D; Mastrangelo V; Pezzullo L; Campbell PJ
    J Manag Care Spec Pharm; 2022 Nov; 28(11):1244-1251. PubMed ID: 36282928
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.